首页> 美国卫生研究院文献>Human Gene Therapy Methods >Limitations of Encapsidation of Recombinant Self-Complementary Adeno-Associated Viral Genomes in Different Serotype Capsids and Their Quantitation
【2h】

Limitations of Encapsidation of Recombinant Self-Complementary Adeno-Associated Viral Genomes in Different Serotype Capsids and Their Quantitation

机译:不同血清型衣壳中重组自互补腺相关病毒基因组衣壳化的局限性及其定量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We previously reported that self-complementary adeno-associated virus (scAAV) type 2 genomes of up to 3.3 kb can be successfully encapsidated into AAV2 serotype capsids. Here we report that such oversized AAV2 genomes fail to undergo packaging in other AAV serotype capsids, such as AAV1, AAV3, AAV6, and AAV8, as determined by Southern blot analyses of the vector genomes, although hybridization signals on quantitative DNA slot-blots could still be obtained. Recently, it has been reported that quantitative real-time PCR assays may result in substantial differences in determining titers of scAAV vectors depending on the distance between the primer sets and the terminal hairpin structure in the scAAV genomes. We also observed that the vector titers determined by the standard DNA slot-blot assays were highly dependent on the specific probe being used, with probes hybridizing to the ends of viral genomes being significantly overrepresented compared with the probes hybridizing close to the middle of the viral genomes. These differences among various probes were not observed using Southern blot assays. This overestimation of titer is a systemic error during scAAV genome quantification, regardless of viral genome sequences and capsid serotypes. Furthermore, different serotypes capsid and modification of capsid sequence may affect the ability of packaging intact, full-length AAV genomes. Although the discrepancy is modest with wild-type serotype capsid and short viral genomes, the measured titer could be as much as fivefold different with capsid mutant vectors and large genomes. Thus, based on our data, we suggest that Southern blot analyses should be performed routinely to more accurately determine the titers of recombinant AAV vectors. At the very least, the use of probes/primers hybridizing close to the mutant inverted terminal repeat in scAAV genomes is recommended to avoid possible overestimation of vector titers.
机译:我们以前曾报道,高达3.3 kb的自我互补腺相关病毒(scAAV)2型基因组可以成功地衣壳化为AAV2血清型衣壳。在这里我们报告了这种超大的AAV2基因组不能包装在其他AAV血清型衣壳中的包装,如通过载体基因组的Southern印迹分析确定的,尽管定量DNA插槽印迹上的杂交信号可能仍然获得。近来,已经报道,定量实时PCR测定法可能导致在确定scAAV载体的效价方面的实质差异,这取决于scAA​​V基因组中的引物组和末端发夹结构之间的距离。我们还观察到,通过标准DNA狭缝印迹测定法确定的载体效价高度依赖于所用的特定探针,与靠近病毒中间杂交的探针相比,与病毒基因组末端杂交的探针明显超标基因组。使用Southern印迹测定法未观察到各种探针之间的这些差异。不管病毒基因组序列和衣壳血清型如何,这种对效价的高估都是scAAV基因组定量过程中的系统性错误。此外,不同的血清型衣壳和衣壳序列的修饰可能影响包装完整的全长AAV基因组的能力。尽管在野生型血清型衣壳和短病毒基因组中差异不大,但对于衣壳突变载体和大基因组,测得的效价可能相差五倍之多。因此,根据我们的数据,我们建议应常规进行Southern印迹分析,以更准确地确定重组AAV载体的效价。至少建议在scAAV基因组中使用与突变的反向末端重复序列接近的探针/引物,以避免对载体滴度的过高估计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号